Gil Roth12.02.13
Phase I
Polaris to begin AML trial . . . read more
Phase II
Exelixis begins CRPC trial . . . read more
Idenix begins HCV trial . . . read more
Filings
Ampio study ruled pivotal for BLA . . . read more
Biogen Idec Alprolix PDUFA date delayed . . . read more
Zalviso NDA accepted by FDA . . . read more
Polaris to begin AML trial . . . read more
Phase II
Exelixis begins CRPC trial . . . read more
Idenix begins HCV trial . . . read more
Filings
Ampio study ruled pivotal for BLA . . . read more
Biogen Idec Alprolix PDUFA date delayed . . . read more
Zalviso NDA accepted by FDA . . . read more